Medicare

The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein

Listen: Pharma goes to Washington, Alnylam’s future, & Gilead’s dealmaking

Politics Rachel Cohrs

STAT Plus: Lawmakers eye partial increase for Medicare doctor pay

Business Brittany Trang

STAT Plus: Private equity investment in Medicare Advantage drops

Politics Rachel Cohrs

STAT Plus: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices

Health Care Inc. Bob Herman

No one’s pleased with the government’s pitch for 2025 Medicare Advantage rates

Letters to the editor Torie Bosch

What STAT readers think about Aduhelm, CTE and the Super Bowl, and more

Exclusive Rachel Cohrs

STAT Plus: Senators start work on Medicare physician payment reform

Politics Bob Herman and Casey Ross

STAT Plus: Senate Democrats push for stronger rules around AI in Medicare Advantage

Politics Rachel Cohrs

STAT Plus: In a showy hearing, Bernie Sanders gets few answers about lower drug prices

D.C. Diagnosis Rachel Cohrs

New pharma CEOs in the hot seat

Pharma Andrew Joseph

STAT Plus: As Medicare drug pricing negotiations begin, AstraZeneca stays mum on government’s offer

Business Casey Ross and Bob Herman

STAT Plus: Government warns Medicare Advantage insurers not to deny care based on AI

Hospitals Tara Bannow

STAT Plus: Medicare threatens to pull funding from HCA’s embattled Mission Hospital

D.C. Diagnosis Sarah Owermohle

STAT Plus: CDC and social media: The new misinformation war

Politics Rachel Cohrs

STAT Plus: The lone Democrat willing to weaken Medicare’s power to negotiate drug prices

Health Care Inc. Bob Herman

Let the Medicare Advantage lobbying begin

Hospitals Tara Bannow

STAT Plus: New Medicare Advantage rule is boon for providers, drag on insurers

Insurance Bob Herman

STAT Plus: Devoted Health’s losses in Medicare Advantage persist

Politics Rachel Cohrs

STAT Plus: Senate working group proposes 340B reforms

First Opinion Diana Zuckerman

Medicare has different standards than the FDA. That’s how it should be

D.C. Diagnosis Rachel Cohrs

Medicare drug price negotiation’s day in court

Politics Rachel Cohrs

STAT Plus: Biden administration makes opening offers in Medicare drug price negotiations

Insurance Bob Herman

STAT Plus: Medicare Advantage insurers face slight proposed cut to 2025 payments

Politics John Wilkerson

STAT Plus: Judge skeptical of arguments against Medicare drug price negotiation

Insurance Bob Herman

Cigna to sell Medicare Advantage plans to Blue Cross Blue Shield insurer for $3.3 billion

D.C. Diagnosis Sarah Owermohle

The end of an era for the FDA’s longtime drug chief

Health Care Inc. Bob Herman

CVS to Oklahoma: Let us steer people to our own pharmacies

Politics Rachel Cohrs

STAT Plus: Merck, Johnson & Johnson CEOs agree to testify in Congress on high drug prices, avoiding Bernie Sanders’ subpoena

Insurance Bob Herman

STAT Plus: Democrats urge government to rein in Medicare Advantage overpayments and denials